Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Nguyen, MT, Vryer, R, Ranganathan, S, Lycett, K, Grobler, A, Dwyer, T, Juonala, M, Saffery, R, Burgner, D, Wake, M.
Telomere Length and Vascular Phenotypes in a Population-Based Cohort of Children and Midlife Adults..
J Am Heart Assoc
8(11)
:
e012707
2019
view publication
Burgner, DP, Newburger, JW.
Etanercept as Adjunctive Primary Therapy in Kawasaki Disease..
Pediatrics
143(6)
:
2019
view publication
Larkins, NG, Teixeira-Pinto, A, Kim, S, Burgner, DP, Craig, JC.
The population-based prevalence of hypertension and correlates of blood pressure among Australian children..
Pediatr Nephrol
34(6)
:
1107 -1115
2019
view publication
Davis, A, Liu, R, Kerr, JA, Wake, M, Grobler, A, Juonala, M, Liu, M, Baur, L, Burgner, D, Lycett, K.
Inflammatory diet and preclinical cardiovascular phenotypes in 11-12 year-olds and mid-life adults: A cross-sectional population-based study..
Atherosclerosis
285:
93 -101
2019
view publication